Restricted adipogenesis in hypertrophic obesity: The role of WISP2, WNT, and BMP4

Diabetes

Volumn 62, Issue 9, 2013, Pages 2997-3004

  Gustafson, Birgit ^a   Hammarstedt, Ann ^a   Hedjazifar, Shahram ^a   Smith, Ulf ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; BONE MORPHOGENETIC PROTEIN 4; INSULIN; UNCLASSIFIED DRUG; WNT INDUCIBLE SECRETED PROTEIN 2; WNT PROTEIN; CCN PROTEIN; REPRESSOR PROTEIN; WISP2 PROTEIN, HUMAN;

ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE CELL; BODY MASS; CAUCASIAN; CELL DIFFERENTIATION; CELL EXPANSION; CELL FATE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HUMAN; HYPERTROPHIC OBESITY; INFLAMMATION; INSULIN RESISTANCE; INSULIN RESPONSE; LIPID STORAGE; MESENCHYMAL STEM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS FAT; TURNOVER TIME; WNT SIGNALING PATHWAY; ADIPOSE TISSUE; ANIMAL; ARTICLE; GENETICS; METABOLISM; PHYSIOLOGY;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; BONE MORPHOGENETIC PROTEIN 4; CCN INTERCELLULAR SIGNALING PROTEINS; HUMANS; OBESITY; REPRESSOR PROTEINS; WNT PROTEINS;

EID: 84887391597     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0473     Document Type: Review

References (57)

1. Whitlock G, Lewington S, Sherliker P, et al.; Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009;373:1083-1096
2. Krotkiewski M, Björntorp P, Sjöström L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983;72:1150-1162
3. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881-887
4. Neeland IJ, Turer AT, Ayers CR, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012;308:1150-1159
5. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808
6. McQuaid SE, Hodson L, Neville MJ, et al. Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes 2011;60:47-55
7. Kotronen A, Yki-Järvinen H, Sevastianova K, et al. Comparison of the relative contributions of intra-abdominal and liver fat to components of the metabolic syndrome. Obesity (Silver Spring) 2011;19:23-28
8. Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome-an allostatic perspective. Biochim Biophys Acta 2010;1801:338-349
9. Ortega FB, Lee DC, Katzmarzyk PT, et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013;34:389-397
10. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998;47:699-713
11. Anand SS, Tarnopolsky MA, Rashid S, et al. Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE). PLoS ONE 2011;6:e22112
12. Chandalia M, Lin P, Seenivasan T, et al. Insulin resistance and body fat distribution in South Asian men compared to Caucasian men. PLoS ONE 2007;2:e812
13. Kishida K, Funahashi T, Matsuzawa Y, Shimomura I. Visceral adiposity as a target for the management of the metabolic syndrome. Ann Med 2012;44: 233-241
14. Jansson PA, Pellmé F, Hammarstedt A, et al. A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin. FASEB J 2003;17:1434-1440
15. Marini MA, Succurro E, Frontoni S, et al. Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care 2007; 30:2145-2147
16. Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008;168: 1609-1616
17. Kimmel AR, Brasaemle DL, McAndrews-Hill M, Sztalryd C, Londos C. Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular lipid storage droplet proteins. J Lipid Res 2010; 51:468-471
18. Semple RK, Sleigh A, Murgatroyd PR, et al. Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest 2009;119:315-322
19. Gavrilova O, Marcus-Samuels B, Graham D, et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 2000; 105:271-278
20. Kim JY, van de Wall E, Laplante M, et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007;117:2621-2637
21. Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005;46:2347-2355
22. Fischer-Posovszky P, Wang QA, Asterholm IW, Rutkowski JM, Scherer PE. Targeted deletion of adipocytes by apoptosis leads to adipose tissue recruitment of alternatively activated M2 macrophages. Endocrinology 2011; 152:3074-3081
23. Isakson P, Hammarstedt A, Gustafson B, Smith U. Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes 2009;58:1550-1557
24. Okuno A, Tamemoto H, Tobe K, et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998;101:1354-1361
25. Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterol-ogy 2012;142:711-725, e6
26. Smith U, Hammarstedt A. Antagonistic effects of thiazolidinediones and cytokines in lipotoxicity. Biochim Biophys Acta 2010;1801:377-380
27. Lönn M, Mehlig K, Bengtsson C, Lissner L. Adipocyte size predicts incidence of type 2 diabetes in women. FASEB J 2010;24:326-331
28. Arner P, Arner E, Hammarstedt A, Smith U. Genetic predisposition for Type 2 diabetes, but not for overweight/obesity, is associated with a restricted adipogenesis. PLoS ONE 2011;6:e18284
29. Gallagher D, Kelley DE, Yim JE, et al.; MRI Ancillary Study Group of the Look AHEAD Research Group. Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr 2009;89:807-814
30. Kotronen A, Juurinen L, Hakkarainen A, et al. Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects. Diabetes Care 2008;31: 165-169
31. Arner E, Westermark PO, Spalding KL, et al. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 2010;59:105-109
32. Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature 2008;453:783-787
33. Tchoukalova YD, Votruba SB, Tchkonia T, Giorgadze N, Kirkland JL, Jensen MD. Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci USA 2010;107:18226-18231
34. Gustafson B, Smith U. The WNT inhibitor Dickkopf 1 and bone morpho-genetic protein 4 rescue adipogenesis in hypertrophic obesity in humans. Diabetes 2012;61:1217-1224
35. Talchai C, Xuan S, Lin HV, Sussel L, Accili D. Pancreatic b cell de-differentiation as a mechanism of diabetic b cell failure. Cell 2012;150: 1223-1234
36. Clevers H, Nusse R. Wnt/b-catenin signaling and disease. Cell 2012;149: 1192-1205
37. Wu Z, Rosen ED, Brun R, et al. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 1999;3:151-158
38. Gordon MD, Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 2006;281:22429-22433
39. Wright WS, Longo KA, Dolinsky VW, et al. Wnt10b inhibits obesity in ob/ob and agouti mice. Diabetes 2007;56:295-303
40. Gustafson B, Eliasson B, Smith U. Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesis. Diabetologia 2010;53:536-540
41. Christodoulides C, Laudes M, Cawthorn WP, et al. The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. J Cell Sci 2006;119:2613-2620
42. Ouchi N, Higuchi A, Ohashi K, et al. Sfrp5 is an anti-inflammatory adipo-kine that modulates metabolic dysfunction in obesity. Science 2010;329: 454-457
43. Ehrlund A, Mejhert N, Lorente-Cebrián S, et al. Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue. J Clin Endocrinol Metab 2013;98:E503-E508
44. Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006;38:320-323
45. Haupt A, Thamer C, Heni M, et al. Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes. Diabetes 2010;59:747-750
46. Villanueva CJ, Waki H, Godio C, et al. TLE3 is a dual-function transcrip-tional coregulator of adipogenesis. Cell Metab 2011;13:413-427
47. Bowers RR, Kim JW, Otto TC, Lane MD. Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene. Proc Natl Acad Sci USA 2006;103:13022-13027
48. Tseng YH, Kokkotou E, Schulz TJ, et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 2008;454: 1000-1004
49. Huang H, Song TJ, Li X, et al. BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci USA 2009;106:12670-12675
50. Zaragosi LE, Wdziekonski B, Villageois P, et al. Activin a plays a critical role in proliferation and differentiation of human adipose progenitors. Diabetes 2010;59:2513-2521
51. Luo X, Hutley LJ, Webster JA, et al. Identification of BMP and activin membrane-bound inhibitor (BAMBI) as a potent negative regulator of adipogenesis and modulator of autocrine/paracrine adipogenic factors. Diabetes 2012;61:124-136
52. Hoggard N, Cruickshank M, Moar KM, Bashir S, Mayer CD. Using gene expression to predict differences in the secretome of human omental vs. subcutaneous adipose tissue. Obesity (Silver Spring) 2012;20:1158-1167
53. Hammarstedt A, Hedjazifar S, Jenndahl L, et al. WISP2 regulates pre-adipocyte commitment and PPARg activation by BMP4. Proc Natl Acad Sci USA 2013;110:2563-2568
54. Sabbah M, Prunier C, Ferrand N, et al. CCN5, a novel transcriptional re-pressor of the transforming growth factor b signaling pathway. Mol Cell Biol 2011;31:1459-1469
55. Gupta RK, Arany Z, Seale P, et al. Transcriptional control of preadipocyte determination by Zfp423. Nature 2010;464:619-623
56. Macotela Y, Emanuelli B, Mori MA, et al. Intrinsic differences in adipocyte precursor cells from different white fat depots. Diabetes 2012;61:1691-1699
57. Arner P, Andersson DP, Thörne A, et al. Variations in the size of the major omentum are primarily determined by fat cell number. J Clin Endocrinol Metab 2013;98:E897-E901